Search - RIIP - Réseau International des Instituts Pasteur Access content directly

Filter your results

33 Results
authFullName_s : Sima Rafati
Image document

Biomarkers of Cutaneous Leishmaniasis

Fariborz Bahrami , Ali M Harandi , Sima Rafati
Frontiers in Cellular and Infection Microbiology, 2018, 8, pp.222. ⟨10.3389/fcimb.2018.00222⟩
Journal articles pasteur-02562277v1

Recombinant Leishmania tarentolae expressing the A2 virulence gene as a novel candidate vaccine against visceral leishmaniasis.

Amir Mizbani , Tahereh Taheri , Farnaz Zahedifard , Yasaman Taslimi , Hiva Azizi , et al.
Vaccine, 2009, 28 (1), pp.53-62. ⟨10.1016/j.vaccine.2009.09.114⟩
Journal articles istex pasteur-00796491v1
Image document

Profiling inflammatory response in lesions of cutaneous leishmaniasis patients using a non-invasive sampling method combined with a high-throughput protein detection assay

Yasaman Taslimi , Christopher Agbajogu , Siggeir Fannar Brynjolfsson , Nasrin Masoudzadeh , Vahid Mashayekhi , et al.
Cytokine, 2020, 130, pp.155056. ⟨10.1016/j.cyto.2020.155056⟩
Journal articles pasteur-02611072v1
Image document

Cationic solid lipid nanoparticles loaded by cysteine proteinase genes as a novel anti-leishmaniasis DNA vaccine delivery system: characterization and in vitro evaluations.

Delaram Doroud , Alireza Vatanara , Farnaz Zahedifard , Elham Gholami , Rouholah Vahabpour , et al.
Journal of Pharmacy and Pharmaceutical Sciences, 2010, 13 (3), pp.320-335. ⟨10.18433/J3R30T⟩
Journal articles pasteur-00786994v1

CD8(+) T cells in leishmania infections: friends or foes?

Simona Stäger , Sima Rafati
Frontiers in Immunology, 2012, 3, pp.5. ⟨10.3389/fimmu.2012.00005⟩
Journal articles pasteur-00814922v1

Leishmania major: Protective capacity of DNA vaccine using amastin fused to HSV-1 VP22 and EGFP in BALB/c mice model.

Azam Bolhassani , Elham Gholami , Farnaz Zahedifard , Neda Moradin , Parto Parsi , et al.
Experimental Parasitology, 2012, 128 (1), pp.9-17. ⟨10.1016/j.exppara.2011.01.012⟩
Journal articles istex pasteur-00786634v1

Searching for virulence factors in the non-pathogenic parasite to humans Leishmania tarentolae.

Hiva Azizi , Kasra Hassani , Yasaman Taslimi , Abdolhossein Rouholamini Najafabadi , Barbara Papadopoulou , et al.
Parasitology, 2009, 136 (7), pp.723-35. ⟨10.1017/S0031182009005873⟩
Journal articles istex pasteur-00796498v1

Immunomodulatory effects of IP-10 chemokine along with PEI600-Tat delivery system in DNA vaccination against HPV infections.

Elham Mohit , Azam Bolhassani , Farnaz Zahedifard , Negar Seyed , Ali Eslamifar , et al.
Molecular Immunology, 2013, 53 (1-2), pp.149-60. ⟨10.1016/j.molimm.2012.07.011⟩
Journal articles pasteur-00789216v1

Improvement of different vaccine delivery systems for cancer therapy.

Azam Bolhassani , Shima Safaiyan , Sima Rafati
Molecular Cancer, 2011, 7 (10), pp.3. ⟨10.1186/1476-4598-10-3⟩
Journal articles pasteur-00789894v1

Heat-shock proteins as powerful weapons in vaccine development.

Azam Bolhassani , Sima Rafati
Expert Review of Vaccines, 2008, 7 (8), pp.1185-99. ⟨10.1586/14760584.7.8.1185⟩
Journal articles pasteur-00796749v1
Image document

In silico analysis of six known Leishmania major antigens and in vitro evaluation of specific epitopes eliciting HLA-A2 restricted CD8 T cell response.

Negar Seyed , Farnaz Zahedifard , Shima Safaiyan , Elham Gholami , Fatemeh Doustdari , et al.
PLoS Neglected Tropical Diseases, 2011, 5 (9), pp.e1295. ⟨10.1371/journal.pntd.0001295⟩
Journal articles pasteur-00787351v1

Different domains of glycoprotein 96 influence HPV16 E7 DNA vaccine potency via electroporation mediated delivery in tumor mice model.

Amin Daemi , Azam Bolhassani , Sima Rafati , Farnaz Zahedifard , Sahar Hosseinzadeh , et al.
Immunology Letters, 2012, 148 (2), pp.117-25. ⟨10.1016/j.imlet.2012.10.003⟩
Journal articles istex pasteur-00789893v1

Th1 cell development induced by cysteine proteinases A and B in localized cutaneous leishmaniasis due to Leishmania guyanensis.

Hervé Pascalis , Pascal Pascalis , Anne Lavergne , Eliane Bourreau , Ghislaine Prévot-Linguet , et al.
Infection and Immunity, 2003, 71 (5), pp.2924-6. ⟨10.1128/IAI.71.5.2924-2926.2003⟩
Journal articles hal-02116562v1

Leishmania infantum: prime boost vaccination with C-terminal extension of cysteine proteinase type I displays both type 1 and 2 immune signatures in BALB/c mice.

Sima Rafati , Farnaz Zahedifard , Mahnaz Kakeh Azari , Yasaman Taslimi , Taheri Tahereh
Experimental Parasitology, 2007, 118 (3), pp.393-401. ⟨10.1016/j.exppara.2007.10.004⟩
Journal articles istex pasteur-00796762v1

Cysteine proteinase type III is protective against Leishmania infantum infection in BALB/c mice and highly antigenic in visceral leishmaniasis individuals.

Naghmeh Khoshgoo , Farnaz Zahedifard , Hiva Azizi , Yasaman Taslimi , Maribel Jiménez Alonso , et al.
Vaccine, 2008, 26 (46), pp.5822-9. ⟨10.1016/j.vaccine.2008.08.065⟩
Journal articles istex pasteur-00796755v1

Leishmaniasis: Middle East and North Africa research and development priorities.

Mary Ann Mcdowell , Sima Rafati , Marcelo Ramalho-Ortigao , Afif Ben Salah
PLoS Neglected Tropical Diseases, 2010, 5 (7), pp.e1219. ⟨10.1371/journal.pntd.0001219⟩
Journal articles pasteur-00784182v1

Cysteine proteinase type I, encapsulated in solid lipid nanoparticles induces substantial protection against Leishmania major infection in C57BL/6 mice.

Delaram Doroud , Farnaz Zahedifard , Alireza Vatanara , Abdolhossein Rouholamini Najafabadi , Sima Rafati
Parasite Immunology, 2011, 33 (6), pp.335-48. ⟨10.1111/j.1365-3024.2011.01289.x⟩
Journal articles pasteur-00789226v1

Evaluation of DNA/DNA and prime-boost vaccination using LPG3 against Leishmania major infection in susceptible BALB/c mice and its antigenic properties in human leishmaniasis.

Abdian Narges , Elham Gholami , Farnaz Zahedifard , Safaee Nozhat , Sima Rafati
Experimental Parasitology, 2010, 127 (3), pp.627-36. ⟨10.1016/j.exppara.2010.12.007⟩
Journal articles istex pasteur-00786950v1

The contribution of NT-gp96 as an adjuvant for increasing HPV16 E7-specific immunity in C57BL /6 mouse model.

Elham Mohit , Azam Bolhassani , Farnaz Zahedifard , Yasaman Taslimi , Sima Rafati
Scandinavian Journal of Immunology, 2011, 75 (1), pp.27-37. ⟨10.1111/j.1365-3083.2011.02620.x⟩
Journal articles istex pasteur-00787345v1

Immunological and genetic evidence for a crucial role of IL-10 in cutaneous lesions in humans infected with Leishmania braziliensis

Adnene Salhi , Jr. Rodrigues , Ferrucio Santoro , Hélia Dessein , Audrey Romano , et al.
Journal of Immunology, 2008, 180 (9), pp.6139-6148. ⟨10.4049/jimmunol.180.9.6139⟩
Journal articles hal-01592701v1

Immune responses elicited by co-immunization of Plasmodium vivax and P. falciparum MSP-1 using prime-boost immunization strategies.

A. A. Mehrizi , S. Zakeri , Sima Rafati , A. H. Salmanian , N. D. Djadid
Parasite Immunology, 2011, 33 (11), pp.594-608. ⟨10.1111/j.1365-3024.2011.01331.x⟩
Journal articles pasteur-00787498v1

Chemokine-based immunotherapy: delivery systems and combination therapies.

Elham Mohit , Sima Rafati
Journal of immunotherapy : official journal of the Society for Biological Therapy, 2012, 4 (8), pp.807-40. ⟨10.2217/imt.12.72⟩
Journal articles pasteur-00789206v1

Leishmania major: disruption of signal peptidase type I and its consequences on survival, growth and infectivity.

Taheri Tahereh , Salmanian Ali-Hatef , Elham Gholami , Fatemeh Doustdari , Farnaz Zahedifard , et al.
Experimental Parasitology, 2010, 126 (2), pp.135-45. ⟨10.1016/j.exppara.2010.04.009⟩
Journal articles istex pasteur-00787030v1

Immunogenic properties of chimeric protein from espA, eae and tir genes of Escherichia coli O157:H7.

Jafar Amani , Ali-Hatef Salmanian , Sima Rafati , Seyed Latif Mousavi
Vaccine, 2010, 28 (42), pp.6923-9. ⟨10.1016/j.vaccine.2010.07.061⟩
Journal articles istex pasteur-00789896v1

Fluorescent Leishmania species: development of stable GFP expression and its application for in vitro and in vivo studies.

Azam Bolhassani , Taheri Tahereh , Yasaman Taslimi , Soheila Zamanilui , Farnaz Zahedifard , et al.
Experimental Parasitology, 2010, 127 (3), pp.637-45. ⟨10.1016/j.exppara.2010.12.006⟩
Journal articles istex pasteur-00786977v1

Delivery of a cocktail DNA vaccine encoding cysteine proteinases type I, II and III with solid lipid nanoparticles potentiate protective immunity against Leishmania major infection.

Delaram Doroud , Farnaz Zahedifard , Alireza Vatanara , Abdolhossein Rouholamini Najafabadi , Yasaman Taslimi , et al.
Journal of Controlled Release, 2011, 153 (3), pp.154-62. ⟨10.1016/j.jconrel.2011.04.011⟩
Journal articles istex pasteur-00786631v1

Cationic solid lipid nanoparticles loaded by cystein proteinase genes as a novel anti-leishmaniasis DNA vaccine delivery system:Characterization and in vitro evaluations.

Delaram Doroud , Alireza Vatanara , Farnaz Zahedifard , Elham Gholami , Rouholah Vahabpour , et al.
Journal of Controlled Release, 2010, 148 (1), pp.e105-106. ⟨10.1016/j.jconrel.2010.07.079⟩
Journal articles istex pasteur-00786930v1

Old World cutaneous leishmaniasis challenges in Morocco, Algeria, Tunisia and Iran (MATI): a collaborative attempt to combat the disease

Fariborz Bahrami , Gerald F Späth , Sima Rafati
Expert Review of Vaccines, 2017, 16 (5), pp.415-417. ⟨10.1080/14760584.2017.1311792⟩
Journal articles pasteur-01974261v1
Image document

C-Terminal Domain Deletion Enhances the Protective Activity of cpa/cpb Loaded Solid Lipid Nanoparticles against Leishmania major in BALB/c Mice.

Delaram Doroud , Farnaz Zahedifard , Alireza Vatanara , Yasaman Taslimi , Rouholah Vahabpour , et al.
PLoS Neglected Tropical Diseases, 2012, 5 (7), pp.e1236. ⟨10.1371/journal.pntd.0001236⟩
Journal articles pasteur-00786600v1
Image document

Polytope DNA vaccine development against hepatitis C virus: a streamlined approach from in silico design to in vitro and primary in vivo analyses in BALB/c mice.

Arash Memarnejadian , Farzin Roohvand , Arash Arashkia , Sima Rafati , Mohammad Ali Shokrgozar
Protein and Peptide Letters, 2009, 16 (7), pp.842-50. ⟨10.2174/092986609788681788⟩
Journal articles pasteur-00744104v1